(Q37992140)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22404554%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Current information on the immunologic status of occult hepatitis B infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22404554%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22404554%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Mohammad Kazemi Arababadi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22404554%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Behzad Nasiri Ahmadabadi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22404554%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

8 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22404554%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22404554%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22404554%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22404554%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

1819-1826

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22404554%20AND%20SRC:MED&resulttype=core&format=json

Molecular testing in the diagnosis and management of chronic hepatitis B

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Occult hepatitis B virus and hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Occult hepatitis B virus infection: a covert operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Assessment of CXCL12 (SDF-1α) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in Southeastern Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Polymorphisms within exon 9 but not intron 8 of the vitamin D receptor are associated with the nephropathic complication of type-2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Functional gene polymorphisms in canadian aboriginal populations with high rates of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Immunopathology of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Distribution of hepatitis B virus DNA sequences in different peripheral blood mononuclear cell subsets in HBs antigen-positive and negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Human genetic determinants of dengue virus susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Anti-HBc screening in Indian blood donors: still an unresolved issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Humoral immune response in Hepatitis B virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Assessment of NK cells response to hepatocyte derived chemotactic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Anti-HIV-1 and anti-HBV immune responses in mice after parenteral and nasal co-administration of a multiantigenic formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

CCR5 in T cell-mediated liver diseases: what's going on?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03575.X

10.1111/J.1537-2995.2012.03575.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22404554%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference